<DOC>
	<DOCNO>NCT00304317</DOCNO>
	<brief_summary>The purpose trial quantify amount Celebrex , specific cyclooxygenase-2 ( COX-2 ) inhibitor , use management acute renal colic ureteral stone : - reduce pain medication usage - improve percentage spontaneous stone passage - decrease time spontaneous passage , - shift size distribution stone pass towards large size</brief_summary>
	<brief_title>Celecoxib ( Celebrex ) Management Acute Renal Colic</brief_title>
	<detailed_description>The study conduct prospective , randomize , double-blind control clinical trial . One-hundred fifty-four patient symptom acute renal colic ureteral calculus le 10 mm large diameter flat plain abdominal x-ray ( KUB ) non-contrast computer tomography ( CT ) scan randomize trial . At time presentation acute renal colic Emergency Department , patient recruit involvement . After informed consent , patient provide either 200 mg Celebrex placebo equivalent . They instruct follow recommend dose regimen acute pain , take two tablet emergency room ( 400 mg ) , follow one tablet 12 hour later ( 200 mg ) , one tablet twice day 10 day . Patients provide prescription Vicodin ( 1-2 tablet 5/500 every 4-6 hour ) take required pain . Throughout study , patient ask strain urine passage calculus note date time passage . Patients also ask maintain daily narcotic diary complete daily pain analog scale provide institution . Patients follow Urology Department 's Stone Clinic weekly imaging study ( KUB CT scan ) renal function test ( serum creatinine ) 4 week .</detailed_description>
	<mesh_term>Calculi</mesh_term>
	<mesh_term>Renal Colic</mesh_term>
	<mesh_term>Ureteral Calculi</mesh_term>
	<mesh_term>Ureterolithiasis</mesh_term>
	<mesh_term>Celecoxib</mesh_term>
	<criteria>Ureteral calculus &lt; = 10 mm large diameter Patient elect conservative management immediate surgical intervention Solitary kidney Renal insufficiency ( creatinine [ CR ] &gt; 1.8 ) Urinary infection ( fever &gt; 101 degree Fahrenheit , positive urine culture , many bacteria urinalysis ) Allergictype reaction sulfonamides Patients know hypersensitivity celecoxib Patients experience asthma , urticaria , allergictype reaction take aspirin nonsteroidal antiinflammatory agent ( NSAIDs ) Prior history gastrointestinal ( GI ) bleed active gastric ulcer disease Pregnancy/nursing Moderatesevere hepatic dysfunction ( ChildPugh Classification B C ) Concomitant use drug inhibit P450 2C9 , drug metabolize P450 2D6 , ACE inhibitor , furosemide , warfarin ( anticoagulant , include lowdose aspirin ) , fluconazole , lithium Women childbearing age unwilling use effective contraception duration trial . Significant unstable cardiovascular disease define : myocardial infarction stroke less 3 month prior study randomization plan revascularization ( percutaneous coronary intervention [ PCI ] coronary artery bypass surgery [ CABG ] ) time study screen angina rest uncontrolled angina hospitalization emergency department visit cardiacrelated illness less 3 month prior randomization uncontrolled hypertension ( define systolic blood pressure [ BP ] &gt; 140 mmHg and/or diastolic BP &gt; 90 mmHg baseline visit ) evidence cardiac electrophysiologic instability include history uncontrolled complex ventricular arrhythmia , uncontrolled atrial fibrillation flutter , uncontrolled supraventricular tachycardia ventricular response heart rate &gt; 100 beat per minute ( BPM ) rest . ( Subjects whose cardiac electrophysiologic instability control pacemaker implantable cardioverter defibrillator ( ICD ) eligible . ) symptom , sign treatment congestive heart failure ( CHF ) know leave ventricular dysfunction ejection fraction &lt; 40 % undergone coronary bypass surgery major surgery ( cardiac noncardiac ) trauma within past 3 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>calculus</keyword>
	<keyword>ureteral calculus</keyword>
	<keyword>ureter</keyword>
</DOC>